A unique downregulation of h2-calponin gene expression in down syndrome: A possible attenuation mechanism for fetal survival by methylation at the CpG island in the trisomic chromosome 21

Molecular and Cellular Biology

Volumn 17, Issue 2, 1997, Pages 707-712

  Kuromitsu, Junro ^a,b   Yamashita, Hideji ^a   Kataoka, Hiroshi ^a,b   Takahara, Tokuei ^a   Muramatsu, Masami ^a   Sekine, Teruaki ^c   Okamoto, Nobuhiko ^d   Furuichi, Yasuhiro ^b   Hayashizaki, Yoshihide ^a  

^a INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^b AGENE Research Institute   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^d RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALPONIN; DNA FRAGMENT;

ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; DOWN SYNDROME; EMBRYO; FEMALE; FETUS; FETUS DEVELOPMENT; GENE DOSAGE; GENE EXPRESSION REGULATION; GENETIC SCREENING; HUMAN; HUMAN CELL; MALE; METAPHASE CHROMOSOME; NEWBORN; PRIORITY JOURNAL; RESTRICTION MAPPING; SPONTANEOUS ABORTION; TRISOMY 21;

EID: 0031046267     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.2.707     Document Type: Article

References (32)

1. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:4113-4111.
2. Bird, A. 1992. The essentials of DNA methylation. Cell 70:5-8.
3. Bond, D. J., and A. C. Chandley. 1983. The origins and causes of aneuploidy in experimental organisms, p. 27-54. In D. J. Bond and A. C. Chandley (ed.), Aneuploidy. Oxford University Press, Oxford, England.
4. Cedar, H. 1988. DNA methylation and gene activity. Cell 53:3-4.
5. Cheng, J.-F., V. Boyartchuk, and V. Zhu. 1994. Isolation and mapping of human chromosome 21 cDNA: progress in constructing a chromosome 21 expression map. Genomics 23:75-84.
6. Coyle, J. T., M. L. Oster-Granite, and J. D. Gearhart. 1986. The neurobiologic consequences of Down syndrome. Brain Res. Bull. 16:773-787.
7. Frischer, H., L. K. Chu, T. Ahmad, P. Justine, and G. F. Smith. 1981. Superoxide dismutase and glulathion peroxidase abnormalities in erythrocytes and lymphoid cells in Down syndrome, p. 269-283. The Red Cell: Fifth Annual Harbor Conference. Liss, New York, N.Y.
8. Gearhart, J. D., M. T. Davisson, and M. L. Oster-Granite. 1986. Autosomal aneuploidy in mice: generation and developmental consequences. Brain Res. Bull. 16:789-801.
9. Gerdes, A. M., M. Horder, P. H. Peterson, and V. Bonnevie-Nielsen. 1993. Effect of increased gene dosage expression on the alpha-interferon receptors in Down's syndrome. Biochim. Biophys. Acta 1181:135-140.
10. Gray, J. W., R. G. Langlois, A. V. Carrano, Burkahart-Schultz, and M. A. Van Dilla. 1979. High resolution chromosome analysis: one and two parameter flow cytometry. Chromosoma 73:9-27.
11. Hayashizaki, Y., S. Hirotsune, Y. Okazaki, I. Hatada, H. Shibata, J. Kawai, K. Hirose, S. Watanabe, S. Fushiki, S. Wada, T. Sugimoto, K. Kubayakawa, T. Kawara, M. Katsuki, T. Shibuya, and T. Mukai. 1993. Restriction landmark genomic scanning method and its various applications. Electrophoresis 14:251-258.
12. Hayashizaki, Y., H. Shibata, S. Hirotsune, H. Sugino, Y. Okazaki, N. Sasaki, K. Hirose, H. Imoto, H. Okuizumi, M. Muramatsu, H. Komatsubara, T. Shiroishi, K. Morikawa, M. Katsuki, N. Hatano, H. Sasaki, T. Ueda, N. Mise, N. Takagi, C. Plass, and V. M. Chapman. 1994. Identification of an imprinted U2af binding protein related sequence on mouse chromosome 11 using the RLGS method. Nat. Genet. 6:33-40.
13. Hirotsune, S., H. Shibata, Y. Okazaki, H. Sugino, H. Imoto, N. Sasaki, K. Hirose, H. Okuizumi, M. Muramatsu, C. Plass, V. M. Chapman, S. Tamatsukuri, C. Miyamoto, Y. Furuichi, and Y. Hayashizaki. 1993. Molecular cloning of polymorphic markers on RLGS gel using the spot target cloning method. Biophys. Biochem. Res. Commun. 194:1406-1412.
14. Holtzman, D. M., and C. J. Epstein. 1992. The molecular genetics of Down syndrome. Mol. Genet. Med. 2:105-120.
15. Hook, E. B. 1981. Down syndrome: its frequency in human populations and some factors pertinent to variations in rates, p. 3-68. In Trisomy 21 (Down syndrome). University Park Press, Baltimore, Md.
16. Kato, K., F. Suzuki, N. Kurobe, K. Okajima, N. Ogasawara, M. Nagaya, and T. Yamanaka. 1991. Enhancement of S-100 beta protein in blood of patients with Down's syndrome. J. Mol. Neurosci. 2:109-113.
17. Kornberg, J. R., X.-N. Chen, R. Schipper, Z. Sun, R. Gonsky, S. Gerwehr, N. Carpenter, C. Daumer, P. Digman, C. Disteche, N. Ogasawara, J. P. Park, R. Pagon, S. Pueschel, G. Sack, B. Say, S. Schuffenhauer, S. Soukup, and T. Yamanaka. 1994. Down syndrome phenotypes: the consequences of chromosomal imbalance. Proc. Natl. Acad. Sci. USA 91:4997-5001.
18. Kuromitsu, J., H. Kataoka, H. Yamashita, M. Muramatsu, Y. Furuichi, T. Sekine, and Y. Hayashizaki. 1995. Reproducible alterations of DNA methylation at a specific population of CpG islands during blast formation of peripheral blood lymphocytes. DNA Res. 2:263-267.
19. Langlois, R. G., L.-C. Yu, J. W. Gray, and A. V. Carrano. 1982. Quantitative karyotyping of human chromosomes by dual beam flow cytometry. Proc. Natl. Acad. Sci. USA 79:7876-7880.
20. Lemieux, N., B. Malfoy, and G. L. Forrest. 1993. Human carbonyl reductase (CBR) localized to band 21q22.1 by high-resolution fluorescence in situ hybridization displays gene dosage effects in trisomy 21 cells. Genomics 15: 169-172.
21. Lindsay, S., and A. P. Bird. 1987. Use of restriction enzyme to detect potential gene sequences in mammalian DNA. Nature 327:336-338.
22. Masuda, H., K. Tanaka, M. Takagi, K. Ohgami, T. Skamaki, N. Shibata, and K. Takahashi. 1996. Molecular cloning and characterization of human non-smooth muscle calponin. J. Biochem. 120:415-424.
23. Nakajima, H., N. Kono, T. Yamasaki, T. Hamaguchi, K. Hotta, M. Kuwajima, T. Noguchi, T. Tanaka, and S. Tarui. 1990. Tissue specificity in expression and alternative RNA splicing of human phosphofructokinase-M and -L genes. Biochem. Biophys. Res. Commun. 173:1317-1321.
24. Ohsumi, T., Y. Okazaki, S. Hirotsune, H. Shibata, M. Muramatsu, H. Suzuki, C. Taga, S. Watanabe, and Y. Hayashizaki. 1995. RLGS spot cloning method. Electrophoresis 16:203-209.
25. Okazaki, Y., H. Okuizumi, N. Sasaki, T. Ohsumi, J. Kuromitsu, H. Kataoka, M. Muramatsu, A. Iwadate, N. Hirota, M. Kitajima, C. Plass, V. M. Chapman, and Y. Hayashizaki. 1994. A genetic linkage map of the mouse using an expanded production system of restriction landmark genomic scanning (RLGS Ver.1.8). Biochem. Biophys. Res. Commun. 205:1922-1929.
26. Pash, J., T. Smithgall, and M. Bustin. 1991. Chromosomal protein HMG-14 is overexpressed in Down syndrome. Exp. Cell Res. 193:232-235.
27. Sekine, T. 1990. Expansion of peripheral blood lymphocytes and tumor-infiltrating lymphocytes stimulated with immobilized anti-CD3 antibody for use in adoptive immunotherapy. Biotherapy 4:1606-1613.
28. Strasser, P., M. Gimona, H. Moessler, M. Herzog, and J. V. Small. 1993. Mammalian calponin: identification and expression of genetic variants. FEBS Lett. 330:13-18.
29. Suzuki, H., J. Kawai, C. Taga, N. Ozawa, and S. Watanabe. 1994. A PCR-mediated method for cloning spot DNA on restriction landmark genomic scanning (RLGS) gel. DNA Res. 1:245-250.
30. Takahashi, K., and B. Nadal-Ginard. 1991. Molecular cloning and sequence analysis of smooth muscle cell. J. Biol. Chem. 266:13284-13288.
31. Taylor, G. M., A. Williams, S. W. D'Souza, W. D. Fergusson, D. Donnai, J. Fennell, and R. Harris. 1988. The expression of CD18 is increased on trisomy 21 (Down syndrome) lymphoblastoid cells. Clin. Exp. Immunol. 71: 324-328.
32. Vora, S., and U. Francke. 1981. Assignment of the human gene for liver-type 6-phosphofructokinase isozyme (PFKL) to chromosome 21 by using somatic cell hybrids and monoclonal anti-L antibody. Proc. Natl. Acad. Sci. USA 78: 3738-3742.